GlassScriptPhysician profile
Charles D Miller
NPI 1417956202
$1,700.07
in general payments reported to CMS, 2019-2025
10 companies · $26.06 in 2025
The $26.06 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $1,289 · 2021: $73.38 · 2022: $74.63 · 2023: $18.85 · 2025: $26.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $1,218.78 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $195.25 | 2019-2023 | Euflexxa |
| Medtronic Vascular, INC. | $83.17 | 2020 | |
| Boston Scientific Corporation | $50.07 | 2019 | |
| Legacy Ortho LLC | $47.34 | 2022-2025 | |
| Smith+Nephew, INC. | $43.71 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $21.45 | 2019 | |
| Pfizer INC. | $15.98 | 2020 | |
| Heraeus Medical, LLC. | $13.50 | 2019 | |
| Merck Sharp & Dohme LLC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.